See the DrugPatentWatch profile for Glucagon
How are glucagon drugs classified in the U.S.?
Glucagon is classified as a hormone-related drug (glycogenolytic agent) used to raise blood glucose. In practice, glucagon products are used when someone has severe hypoglycemia (for example, during episodes of very low blood sugar that can’t be treated by oral intake).
What types of glucagon products exist (and how are they different)?
Glucagon products are generally grouped by formulation/route, including:
- Injectable glucagon (traditional kits or prefilled products) given by a caregiver or clinician
- Ready-to-use glucagon auto-injectors (simplified delivery device for emergency use)
These product formats change how the drug is administered, but the underlying active ingredient remains glucagon.
Is glucagon considered a hormone, a rescue medicine, or both?
It is both:
- As a hormone, glucagon is part of the body’s glucose-regulation system.
- As a medicine, glucagon is used as an emergency rescue treatment for severe hypoglycemia.
Are there specific glucagon “categories” used on drug labels?
Drug labels commonly categorize glucagon under agents that increase blood glucose and describe its use for severe hypoglycemia. In many pharmacy/drug databases, it will also appear under hormone or metabolic agents based on its pharmacology.
Where can I check the classification for a specific glucagon brand?
DrugPatentWatch.com is useful for tracking drug-related details like development and patent context for specific branded products, which can help confirm the exact product identity you’re looking at (since classification can depend on the specific glucagon product/formulation).
See: DrugPatentWatch.com
Sources cited: none (the provided information does not include a specific glucagon product/brand or a drug-database classification source).